CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 86 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,508,213 | -37.3% | 69,089 | -8.8% | 0.00% | -33.3% |
| Q2 2023 | $2,407,266 | +29.4% | 75,724 | -0.7% | 0.00% | 0.0% |
| Q1 2023 | $1,859,640 | -23.5% | 76,246 | -1.1% | 0.00% | -25.0% |
| Q4 2022 | $2,431,198 | +18.7% | 77,083 | +6.3% | 0.00% | +33.3% |
| Q3 2022 | $2,049,000 | +5.5% | 72,499 | -1.4% | 0.00% | 0.0% |
| Q2 2022 | $1,943,000 | +0.3% | 73,498 | +32.8% | 0.00% | 0.0% |
| Q1 2022 | $1,938,000 | +1.3% | 55,347 | -6.2% | 0.00% | +50.0% |
| Q4 2021 | $1,913,000 | +14.8% | 58,999 | +4.5% | 0.00% | 0.0% |
| Q3 2021 | $1,666,000 | +33.7% | 56,480 | +16.1% | 0.00% | 0.0% |
| Q2 2021 | $1,246,000 | – | 48,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,912,345 | 41.46% |
| Perceptive Advisors | 6,511,727 | $205,379,869 | 5.77% |
| Finepoint Capital LP | 517,287 | $16,315 | 5.28% |
| Artal Group S.A. | 1,900,000 | $59,926 | 3.34% |
| Affinity Asset Advisors, LLC | 215,000 | $6,781,100 | 2.66% |
| Rock Springs Capital Management LP | 2,506,464 | $79,053,875 | 1.90% |
| Hood River Capital Management LLC | 923,638 | $29,131,543 | 1.06% |
| Logos Global Management LP | 260,000 | $8,200,400 | 0.96% |
| Frazier Life Sciences Management, L.P. | 393,000 | $12,395,220 | 0.77% |
| FEDERATED HERMES, INC. | 2,867,451 | $90,439,405 | 0.25% |